
-
抗体試薬
- フローサイトメトリー用試薬
-
ウェスタンブロッティング抗体試薬
- イムノアッセイ試薬
-
シングルセル試薬
- BD® AbSeq Assay
- BD Rhapsody™ Accessory Kits
- BD® OMICS-One Immune Profiler Protein Panel
- BD® Single-Cell Multiplexing Kit
- BD Rhapsody™ TCR/BCR Next Multiomic Assays
- BD Rhapsody™ Targeted mRNA Kits
- BD Rhapsody™ Whole Transcriptome Analysis (WTA) Amplification Kit
- BD® OMICS-Guard Sample Preservation Buffer
- BD Rhapsody™ ATAC-Seq Assays
- BD® OMICS-One Protein Panels
-
細胞機能評価のための試薬
-
顕微鏡・イメージング用試薬
-
細胞調製・分離試薬
-
- BD® AbSeq Assay
- BD Rhapsody™ Accessory Kits
- BD® OMICS-One Immune Profiler Protein Panel
- BD® Single-Cell Multiplexing Kit
- BD Rhapsody™ TCR/BCR Next Multiomic Assays
- BD Rhapsody™ Targeted mRNA Kits
- BD Rhapsody™ Whole Transcriptome Analysis (WTA) Amplification Kit
- BD® OMICS-Guard Sample Preservation Buffer
- BD Rhapsody™ ATAC-Seq Assays
- BD® OMICS-One Protein Panels
- Japan (Japanese)
-
Change country/language
Old Browser
Looks like you're visiting us from United States.
Would you like to stay on the current country site or be switched to your country?
BD Horizon™ R718 Rat Anti-Galectin-3
クローン M3/38 (RUO)

Galectin-3 Expression by Human and Mouse Leucocytes
1. Surface_Neutrophils Human blood was stained with BD Horizon™ R718 Rat IgG2a, κ Isotype Control (Cat. No. 566941; dashed histogram) or BD Horizon™ R718 Rat Anti-Galectin-3 (Cat. No. 568404/568405; solid line histogram) at 1 µg/test. Erythrocytes were lysed with BD Pharm Lyse™ Lysing Buffer (Cat. No. 555899). A histogram showing Surface Galectin-3 expression (or Ig Isotype control staining) was derived from gated events with the forward and side light-scatter characteristics of viable neutrophils.
2. Surface + Intracellular_PBMC Peripheral blood mononuclear cells (PBMC) were preincubated with Human BD Fc Block™ (Cat. No. 564219/564220), fixed with BD Cytofix™ Fixation Buffer (Cat. No. 554655), and permeabilized with BD Perm/Wash™ Buffer (Cat. No. 554723). Cells were then stained with PE Mouse Anti-Human CD11b (Cat. No. 555388) and with either BD Horizon™ R718 Rat IgG2a, κ Isotype Control or BD Horizon™ R718 Rat Anti-Galectin-3. The bivariate pseudocolor density plot shows the correlated expression of total cellular Galectin-3 (or Ig Isotype control staining) versus CD11b by gated intact PBMC.
3. Surface_PEC Thioglycolate-elicited C57BL/6 Mouse peritoneal exudate cells (Thio-PEC) were preincubated with Purified Rat Anti-Mouse CD16/CD32 Ab (Mouse BD Fc Block™) and stained with either BD Horizon™ R718 Rat IgG2a, κ Isotype Control (dashed line histogram) or BD Horizon™ R718 Rat Anti-Galectin-3 (solid line histogram) at 1 µg/test. The histogram shows Surface Galectin-3 expression (or Ig Isotype control staining) on viable (DAPI-negative) [Cat. 564907] Thio-PEC.
4. Surface + Intracellular_PEC Thio-PEC were similarly fixed, permeabilized and stained (without DAPI). The histogram shows total cellular Galectin-3 expression (or Ig Isotype control staining) by intact Thio-PEC.
Flow cytometry and analysis were performed using a BD LSRFortessa™ Cell Analyzer System and FlowJo™ software. Data shown are not lot specific.

Galectin-3 Expression by Human and Mouse Leucocytes
1. Surface_Neutrophils Human blood was stained with BD Horizon™ R718 Rat IgG2a, κ Isotype Control (Cat. No. 566941; dashed histogram) or BD Horizon™ R718 Rat Anti-Galectin-3 (Cat. No. 568404/568405; solid line histogram) at 1 µg/test. Erythrocytes were lysed with BD Pharm Lyse™ Lysing Buffer (Cat. No. 555899). A histogram showing Surface Galectin-3 expression (or Ig Isotype control staining) was derived from gated events with the forward and side light-scatter characteristics of viable neutrophils.
2. Surface + Intracellular_PBMC Peripheral blood mononuclear cells (PBMC) were preincubated with Human BD Fc Block™ (Cat. No. 564219/564220), fixed with BD Cytofix™ Fixation Buffer (Cat. No. 554655), and permeabilized with BD Perm/Wash™ Buffer (Cat. No. 554723). Cells were then stained with PE Mouse Anti-Human CD11b (Cat. No. 555388) and with either BD Horizon™ R718 Rat IgG2a, κ Isotype Control or BD Horizon™ R718 Rat Anti-Galectin-3. The bivariate pseudocolor density plot shows the correlated expression of total cellular Galectin-3 (or Ig Isotype control staining) versus CD11b by gated intact PBMC.
3. Surface_PEC Thioglycolate-elicited C57BL/6 Mouse peritoneal exudate cells (Thio-PEC) were preincubated with Purified Rat Anti-Mouse CD16/CD32 Ab (Mouse BD Fc Block™) and stained with either BD Horizon™ R718 Rat IgG2a, κ Isotype Control (dashed line histogram) or BD Horizon™ R718 Rat Anti-Galectin-3 (solid line histogram) at 1 µg/test. The histogram shows Surface Galectin-3 expression (or Ig Isotype control staining) on viable (DAPI-negative) [Cat. 564907] Thio-PEC.
4. Surface + Intracellular_PEC Thio-PEC were similarly fixed, permeabilized and stained (without DAPI). The histogram shows total cellular Galectin-3 expression (or Ig Isotype control staining) by intact Thio-PEC.
Flow cytometry and analysis were performed using a BD LSRFortessa™ Cell Analyzer System and FlowJo™ software. Data shown are not lot specific.

Galectin-3 Expression by Human and Mouse Leucocytes
1. Surface_Neutrophils Human blood was stained with BD Horizon™ R718 Rat IgG2a, κ Isotype Control (Cat. No. 566941; dashed histogram) or BD Horizon™ R718 Rat Anti-Galectin-3 (Cat. No. 568404/568405; solid line histogram) at 1 µg/test. Erythrocytes were lysed with BD Pharm Lyse™ Lysing Buffer (Cat. No. 555899). A histogram showing Surface Galectin-3 expression (or Ig Isotype control staining) was derived from gated events with the forward and side light-scatter characteristics of viable neutrophils.
2. Surface + Intracellular_PBMC Peripheral blood mononuclear cells (PBMC) were preincubated with Human BD Fc Block™ (Cat. No. 564219/564220), fixed with BD Cytofix™ Fixation Buffer (Cat. No. 554655), and permeabilized with BD Perm/Wash™ Buffer (Cat. No. 554723). Cells were then stained with PE Mouse Anti-Human CD11b (Cat. No. 555388) and with either BD Horizon™ R718 Rat IgG2a, κ Isotype Control or BD Horizon™ R718 Rat Anti-Galectin-3. The bivariate pseudocolor density plot shows the correlated expression of total cellular Galectin-3 (or Ig Isotype control staining) versus CD11b by gated intact PBMC.
3. Surface_PEC Thioglycolate-elicited C57BL/6 Mouse peritoneal exudate cells (Thio-PEC) were preincubated with Purified Rat Anti-Mouse CD16/CD32 Ab (Mouse BD Fc Block™) and stained with either BD Horizon™ R718 Rat IgG2a, κ Isotype Control (dashed line histogram) or BD Horizon™ R718 Rat Anti-Galectin-3 (solid line histogram) at 1 µg/test. The histogram shows Surface Galectin-3 expression (or Ig Isotype control staining) on viable (DAPI-negative) [Cat. 564907] Thio-PEC.
4. Surface + Intracellular_PEC Thio-PEC were similarly fixed, permeabilized and stained (without DAPI). The histogram shows total cellular Galectin-3 expression (or Ig Isotype control staining) by intact Thio-PEC.
Flow cytometry and analysis were performed using a BD LSRFortessa™ Cell Analyzer System and FlowJo™ software. Data shown are not lot specific.

BD Horizon™ R718 Rat Anti-Galectin-3
Regulatory Statusの凡例
Any use of products other than the permitted use without the express written authorization of Becton, Dickinson and Company is strictly prohibited.
Preparation and Storage
推奨アッセイ手順
BD® CompBeads can be used as surrogates to assess fluorescence spillover (compensation). When fluorochrome conjugated antibodies are bound to BD® CompBeads, they have spectral properties very similar to cells. However, for some fluorochromes there can be small differences in spectral emissions compared to cells, resulting in spillover values that differ when compared to biological controls. It is strongly recommended that when using a reagent for the first time, users compare the spillover on cells and BD® CompBeads to ensure that BD® CompBeads are appropriate for your specific cellular application.
Product Notices
- Please refer to www.bdbiosciences.com/us/s/resources for technical protocols.
- Since applications vary, each investigator should titrate the reagent to obtain optimal results.
- An isotype control should be used at the same concentration as the antibody of interest.
- Caution: Sodium azide yields highly toxic hydrazoic acid under acidic conditions. Dilute azide compounds in running water before discarding to avoid accumulation of potentially explosive deposits in plumbing.
- Please refer to http://regdocs.bd.com to access safety data sheets (SDS).
- This product is provided under an Agreement between BIOTIUM and BD Biosciences. This product, and only in the amount purchased by buyer, may be used solely for buyer’s own internal research, in a manner consistent with the accompanying product literature. No other right to use, sell or otherwise transfer (a) this product, or (b) its components is hereby granted expressly, by implication or by estoppel. This product is for research use only. Diagnostic uses require a separate license from Biotium, Inc. For information on purchasing a license to this product including for purposes other than research, contact Biotium, Inc., 3159 Corporate Place, Hayward, CA 94545, Tel: (510) 265-1027. Fax: (510) 265-1352. Email: btinfo@biotium.com.
- Species cross-reactivity detected in product development may not have been confirmed on every format and/or application.
- Alexa Fluor™ is a trademark of Life Technologies Corporation.
- For U.S. patents that may apply, see bd.com/patents.
関連製品






The M3/38 monoclonal antibody specifically recognizes Galectin-3 (Gal-3 or gal3) which is also known as Galactose-specific lectin 3, Mac-2, MAC2, and Carbohydrate-binding protein 35 (CBP 35). Galectin-3 is an ~30-35 kDa protein that includes an N-terminal proline-rich tandem repeat domain as well as a C-terminal region with one carbohydrate recognition domain (CRDs). Galectin-3 is encoded by Lgals3 (lectin, galactose binding, soluble 3) which belongs to the galectin family. It is expressed by a variety of cells including activated macrophages, dendritic cells (DCs), granulocytes, mast cells, and epithelial cells. Galectin-3 can be detected in monomeric or multimeric forms in cytoplasmic, nuclear, cell surface and extracellular locations. Galectin-3 is a β-galactoside-binding lectin that has multiple intracellular and extracellular functions implicated in biological processes including RNA splicing as well as cellular chemoattraction and adhesion, activation, growth, proliferation, differentiation, and apoptosis. Upregulated Galectin-3 expression is implicated in inflammation and disease states including cancer progression and metastasis.

Development References (8)
-
Demotte N, Wieërs G, Van Der Smissen P, et al. A galectin-3 ligand corrects the impaired function of human CD4 and CD8 tumor-infiltrating lymphocytes and favors tumor rejection in mice.. Cancer Res. 2010; 70(19):7476-88. (Clone-specific: Flow cytometry). View Reference
-
Dong R, Zhang M, Hu Q, et al. Galectin-3 as a novel biomarker for disease diagnosis and a target for therapy (Review).. Int J Mol Med. 2018; 41(2):599-614. (Biology). View Reference
-
Flotte TJ, Springer TA, Thorbecke GJ. Dendritic cell and macrophage staining by monoclonal antibodies in tissue sections and epidermal sheets. Am J Pathol. 1983; 111(1):112-124. (Clone-specific: Immunohistochemistry). View Reference
-
Gray RM, Davis MJ, Ruby KM, Voss PG, Patterson RJ, Wang JL. Distinct effects on splicing of two monoclonal antibodies directed against the amino-terminal domain of galectin-3.. Arch Biochem Biophys. 2008; 475(2):100-8. (Clone-specific: Functional assay, Western blot). View Reference
-
Ho MK, Springer TA. Mac-2, a novel 32,000 Mr mouse macrophage subpopulation-specific antigen defined by monoclonal antibodies.. J Immunol. 1982; 128(3):1221-8. (Immunogen: Flow cytometry, Immunoprecipitation, Radioimmunoassay). View Reference
-
Johannes L, Jacob R, Leffler H. Galectins at a glance.. J Cell Sci. 2018; 131(9):jcs208884. (Biology). View Reference
-
Karlsson A, Follin P, Leffler H, Dahlgren C. Galectin-3 activates the NADPH-oxidase in exudated but not peripheral blood neutrophils.. Blood. 1998; 91(9):3430-8. (Clone-specific: Flow cytometry). View Reference
-
Newlaczyl AU, Yu LG. Galectin-3--a jack-of-all-trades in cancer.. Cancer Lett. 2011; 313(2):123-8. (Biology). View Reference
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.